Patient NAME : Ms Reeta keshari

DOB/Age/Gender : 45 Y/Female Report STATUS : Final Report

Patient ID / UHID : 11235979/RCL10417368 Barcode NO : HR226788
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : Jan 31, 2025, 10:13 AM Report Date : Jan 31, 2025, 11:13 AM.
Test Description Value(s) Unit(s) Reference Range

Smart Full Body Checkup

Complete Blood Count (CBC)

RBC Parameters
Hemoglobin 12.3 g/dL 12.0 - 15.0
colorimetric
RBC Count 4.2 10^6/µl 3.8 - 4.8
Electrical impedance
PCV 38.3 % 36 - 46
Calculated
MCV 90.8 fl 83 - 101
Calculated
MCH 29.2 pg 27 - 32
Calculated
MCHC 32.1 g/dL 31.5 - 34.5
Calculated
RDW (CV) * 13.9 % 11.6 - 14.0
Calculated
RDW-SD * 51.2 fl 35.1 - 43.9
Calculated
WBC Parameters
TLC 7.4 10^3/µl 4 - 10
Electrical impedance and microscopy
Differential Leucocyte Count
Neutrophils 73 % 40-80
Lymphocytes 23 % 20-40
Monocytes 3 % 2-10
Eosinophils 1 % 1-6
Basophils 0 % <2
Absolute Leukocyte Counts
Calculated
Neutrophils. 5.4 10^3/µl 2-7
Lymphocytes. 1.7 10^3/µl 1-3
Monocytes. 0.22 10^3/µl 0.2 - 1.0
Eosinophils. 0.07 10^3/µl 0.02 - 0.5
Basophils. 0 10^3/µl 0.02 - 0.5
Platelet Parameters
Platelet Count 158 10^3/µl 150 - 410
Electrical impedance and microscopy
Mean Platelet Volume (MPV) * 13.9 fL 9.3 - 12.1
Calculated
PCT * 0.2 % 0.17 - 0.32
Calculated
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., H.No.31/82A-9-B Rashmi Nagar, Near BHU Hospital, Varanasi-221005

Page 1 of 12
 Patient NAME : Ms Reeta keshari
DOB/Age/Gender : 45 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11235979/RCL10417368 Barcode NO : HR226788
Referred BY : Self Sample Type : Whole blood EDTA
Sample Collected : Jan 31, 2025, 10:13 AM Report Date : Jan 31, 2025, 11:13 AM.
Test Description Value(s) Unit(s) Reference Range
PDW * 31 fL 8.3 - 25.0
Calculated
Mentzer Index * 21.62 % > 13
Calculated

Interpretation:
CBC provides information about red cells, white cells and platelets. Results are useful in the diagnosis of anemia, infections, leukemias, clotting
disorders and many other medical conditions.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., H.No.31/82A-9-B Rashmi Nagar, Near BHU Hospital, Varanasi-221005

Page 2 of 12
 Patient NAME : Ms Reeta keshari
DOB/Age/Gender : 45 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11235979/RCL10417368 Barcode NO : HR226788
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : Jan 31, 2025, 10:13 AM Report Date : Jan 31, 2025, 01:34 PM.
Test Description Value(s) Unit(s) Reference Range

Erythrocyte Sedimentation Rate (ESR)

ESR - Erythrocyte Sedimentation Rate 15 mm/hr 0 - 12

MODIFIED WESTERGREN

Interpretation:
ESR is also known as Erythrocyte Sedimentation Rate. An ESR test is used to assess inflammation in the body. Many conditions can cause an
abnormal ESR, so an ESR test is typically used with other tests to diagnose and monitor different diseases. An elevated ESR may occur in
inflammatory conditions including infection, rheumatoid arthritis ,systemic vasculitis, anemia, multiple myeloma , etc. Low levels are typically
seen in congestive heart failure, polycythemia ,sickle cell anemia, hypo fibrinogenemia , etc.

Reference- Dacie and lewis practical hematology

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., H.No.31/82A-9-B Rashmi Nagar, Near BHU Hospital, Varanasi-221005

Page 3 of 12
 Patient NAME : Ms Reeta keshari
DOB/Age/Gender : 45 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11235979/RCL10417368 Barcode NO : ZH268158
Referred BY : Self Sample Type : FLUORIDE F
....

Sample Collected : Jan 31, 2025, 10:13 AM Report Date : Jan 31, 2025, 11:54 AM.
Test Description Value(s) Unit(s) Reference Range

Glucose Fasting

Glucose Fasting 84.3 mg/dL 70 - 100

Hexokinase

Interpretation:
Status Fasting plasma glucose in mg/dL
Normal <100
Impaired fasting glucose 100 - 125
Diabetes =>126

Reference : American Diabetes Association

Comment :
Blood glucose determinations in commonly used as an aid in the diagnosis and treatment of diabetes. Elevated glucose levels (hyperglycemia)
may also occur with pancreatic neoplasm, hyperthyroidism, and adrenal cortical hyper function as well as other disorders. Decreased glucose
levels (hypoglycemia) may result from excessive insulin therapy insulinoma, or various liver diseases.

Note
1.The diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL or a random / 2 hour plasma glucose value of > or = 200
mg/dL with symptoms of diabetes mellitus.
2.Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., H.No.31/82A-9-B Rashmi Nagar, Near BHU Hospital, Varanasi-221005

Page 4 of 12
 Patient NAME : Ms Reeta keshari
DOB/Age/Gender : 45 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11235979/RCL10417368 Barcode NO : ZH268159
Referred BY : Self Sample Type : Serum
....

Sample Collected : Jan 31, 2025, 10:13 AM Report Date : Jan 31, 2025, 12:54 PM.
Test Description Value(s) Unit(s) Reference Range

Liver Function Test (LFT)

Bilirubin Total 0.4 mg/dL 0.2 - 1.2

Photometric
Bilirubin Direct * 0.2 mg/dL 0.0 - 0.5
Diazo Reaction
Bilirubin Indirect * 0.2 mg/dL 0.1 - 1.0
Calculation (T Bil - D Bil)
SGOT/AST 19.8 U/L 5 - 34
IFCC without P5P
SGPT/ALT 16.8 U/L 0 to 55
IFCC without P5P
SGOT/SGPT Ratio * 1.18 - -
Alkaline Phosphatase 69.8 U/L 40 - 150
IFCC
Total Protein 6.9 g/dL 6.4 - 8.3
Biuret
Albumin 4.6 gm/dL 3.8 - 5.0
BCG
Globulin * 2.3 g/dL 2.3 - 3.5
Calculation (T.P - Albumin)
Albumin :Globulin Ratio * 2 - 1.0 - 2.1
Calculation (Albumin/Globulin)
Gamma Glutamyl Transferase (GGT) * 24.7 U/L 9 to 36
Photometric

Interpretation:
The liver filters and processes blood as it circulates through the body. It metabolizes nutrients, detoxifies harmful substances, makes blood
clotting proteins, and performs many other vital functions. The cells in the liver contain proteins called enzymes that drive these chemical
reactions. When liver cells are damaged or destroyed, the enzymes in the cells leak out into the blood, where they can be measured by blood
tests Liver tests check the blood for two main liver enzymes. Aspartate aminotransferase (AST),SGOT: The AST enzyme is also found in
muscles and many other tissues besides the liver. Alanine aminotransferase (ALT), SGPT: ALT is almost exclusively found in the liver. If ALT
and AST are found together in elevated amounts in the blood, liver damage is most likely present. Alkaline Phosphatase and GGT: Another of
the liver's key functions is the production of bile, which helps digest fat. Bile flows through the liver in a system of small tubes (ducts), and is
eventually stored in the gallbladder, under the liver. When bile flow is slow or blocked, blood levels of certain liver enzymes rise: Alkaline
phosphatase Gamma-utamyl transpeptidase (GGT) Liver tests may check for any or all of these enzymes in the blood. Alkaline phosphatase is
by far the most commonly tested of the three. If alkaline phosphatase and GGT are elevated, a problem with bile flow is most likely present. Bile
flow problems can be due to a problem in the liver, the gallbladder, or the tubes connecting them. Proteins are important building blocks of all
cells and tissues. Proteins are necessary for your body's growth, development, and health. Blood contains two classes of protein, albumin and
globulin. Albumin proteins keep fluid from leaking out of blood vessels. Globulin proteins play an important role in your immune system. Low
total protein may

Indicate:
1.Bleeding
2.Liver disorder
3.Malnutrition
4.Agammaglobulinemia High Protein levels 'Hyperproteinemia: May be seen in dehydration due to inadequate water intake or to excessive
water loss (eg, severe vomiting, diarrhea, Addison's disease and diabetic acidosis) or as a result of increased production of proteins Low
albumin levels may be

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., H.No.31/82A-9-B Rashmi Nagar, Near BHU Hospital, Varanasi-221005

Page 5 of 12
 Patient NAME : Ms Reeta keshari
DOB/Age/Gender : 45 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11235979/RCL10417368 Barcode NO : ZH268159
Referred BY : Self Sample Type : Serum
Sample Collected : Jan 31, 2025, 10:13 AM Report Date : Jan 31, 2025, 12:54 PM.
Test Description Value(s) Unit(s) Reference Range

Caused by:
1.A poor diet (malnutrition).
2.Kidney disease.
3.Liver disease. High albumin levels may be caused by: Severe dehydration.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., H.No.31/82A-9-B Rashmi Nagar, Near BHU Hospital, Varanasi-221005

Page 6 of 12
 Patient NAME : Ms Reeta keshari
DOB/Age/Gender : 45 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11235979/RCL10417368 Barcode NO : ZH268159
Referred BY : Self Sample Type : Serum
....

Sample Collected : Jan 31, 2025, 10:13 AM Report Date : Jan 31, 2025, 12:54 PM.
Test Description Value(s) Unit(s) Reference Range

Kidney Function Test (KFT)

Blood Urea 19.2 mg/dL 19 - 44.1

Urease
Bun * 8.97 mg/dL 7.0 - 18.7
Urease
Creatinine 0.7 mg/dL 0.57 - 1.11
Photometric
eGFR (CKD-EPI) 108.60 ml/min/1.73 sq m Normal Or High: >= 90

Mild Or Decrease: 60-89

Mild To Moderate Decrease:

45-59

Mild To Severe Decrease:

30-44

Severe Decrease: 15-29

Kidney Failure: < 15

Bun/Creatinine Ratio * 12.81 12 - 20
Calculated
Urea / Creatinine Ratio * 27.43 25.68- 42.8
Calculated
Uric Acid 3.7 mg/dL 2.6 - 6.0
Uricase
Calcium Serum 9.4 mg/dL 8.4 - 10.2
Arsenazo III
Phosphorus 3.1 mg/dL 2.3 - 4.7
Photometric
Sodium 140 mmol/L 136 - 145
Potentiometric
Potassium 5.0 mmol/L 3.5 - 5.1
Potentiometric
Chloride 106 mmol/L 98 - 107
Photometric

Interpretation:
Kidney function tests is a collective term for a variety of individual tests and proceduresthat can be done toevaluate how well the kidneys are functioning. Many
conditions can affect the ability of the kidneys to carryout their vital functions. Somelead to a rapid (acute) decline in kidney functionothers lead to a gradual (chronic)
declineinfunction. Both result in a buildup of toxic waste subst done on urine samples, as well as on blood samples. A number of symptoms may indicate a problem with
your kidneys. These include : high blood pressure,blood in urine frequent urges to urinate,difficulty beginning urination,painful urination,swelling in the hands and feet due
to a buildup of fluids in the body. A single symptom may not mean something serious. However, when occurring simultaneously, these symptoms suggest that your
kidneys are not working properly. Kidney function tests can help determine the reason. Electrolytes are present in the human body and the balancing act of the
electrolytes in our bodies is essential for normal function of our cells and organs. There has to be a balance.Ionized calcium this test if you have signs of kidney or
parathyroid disease. The test may also be done to monitor progress and treatment of these diseases.
"eGFR test is applicable for patients aged 18 years or more."

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., H.No.31/82A-9-B Rashmi Nagar, Near BHU Hospital, Varanasi-221005

Page 7 of 12
 Patient NAME : Ms Reeta keshari
DOB/Age/Gender : 45 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11235979/RCL10417368 Barcode NO : ZH268159
Referred BY : Self Sample Type : Serum
Sample Collected : Jan 31, 2025, 10:13 AM Report Date : Jan 31, 2025, 12:54 PM.
Test Description Value(s) Unit(s) Reference Range

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., H.No.31/82A-9-B Rashmi Nagar, Near BHU Hospital, Varanasi-221005

Page 8 of 12
 Patient NAME : Ms Reeta keshari
DOB/Age/Gender : 45 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11235979/RCL10417368 Barcode NO : ZH268159
Referred BY : Self Sample Type : Serum
....

Sample Collected : Jan 31, 2025, 10:13 AM Report Date : Jan 31, 2025, 12:54 PM.
Test Description Value(s) Unit(s) Reference Range

Lipid Profile

Total Cholesterol 146 mg/dL <200

Enzymatic - Cholesterol Oxidase
Triglycerides 54.7 mg/dL <150
Colorimetric - Lip/Glycerol Kinase
HDL Cholesterol 63.6 mg/dL >40
Accelerator Selective Detergent
Non HDL Cholesterol * 82.4 mg/dL <130
Calculated
LDL Cholesterol * 71.46 mg/dL <100
Calculated
V.L.D.L Cholesterol * 10.94 mg/dL < 30
Calculated
Chol/HDL Ratio * 2.3 Ratio 3.5 - 5.0
Calculated
HDL/ LDL Ratio * 0.89 Ratio 0.5 - 3.0
Calculated
LDL/HDL Ratio * 1.12 Ratio -
Calculated

Interpretation:
Lipid level assessments must be made following 9 to 12 hours of fasting, otherwise assay results might lead to erroneous interpretation. NCEP recommends of 3
different samples to be drawn at intervals of 1 week for harmonizing biological variables that might be encountered in single assays.

National Lipid Association Recommendations Total Cholesterol Triglyceride LDL Cholesterol Non HDL Cholesterol
(NLA-2014) (mg/dL) (mg/dL) (mg/dL) (mg/dL)
Optimal <200 <150 <100 <130
Above Optimal 100-129 130 - 159
Borderline High 200-239 150-199 130-159 160 - 189
High >=240 200-499 160-189 190 - 219
Very High - >=500 >=190 >=220

HDL Cholesterol
Low High
<40 >=60

Risk Stratification for ASCVD (Atherosclerotic Cardiovascular Disease) by Lipid Association of India.

Risk Category A. CAD with > 1 feature of high risk group

B. CAD with >1 feature of very high risk group of recurrent ACS (within 1 year) despite LDL-C <or = 50 mg/dl
Extreme risk group
or poly vascular disease
1.Established ASCVD 2.Diabetes with 2 major risk factors of evidence of end organ
Very High Risk
damage 3. Familial Homozygous Hypercholesterolemia
1. Three major ASCVD risk factors 2. Diabetes with 1 major risk factor or no evidence

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., H.No.31/82A-9-B Rashmi Nagar, Near BHU Hospital, Varanasi-221005

Page 9 of 12
 Patient NAME : Ms Reeta keshari
DOB/Age/Gender : 45 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11235979/RCL10417368 Barcode NO : ZH268159
Referred BY : Self Sample Type : Serum
Sample Collected : Jan 31, 2025, 10:13 AM Report Date : Jan 31, 2025, 12:54 PM.
Test Description Value(s) Unit(s) Reference Range
of end organ damage 3. CHD stage 3B or 4. 4 LDL >190 mg/dl 5. Extreme of a single
High Risk
risk factor 6. Coronary Artery Calcium - CAC > 300 AU 7. Lipoprotein a >/= 50 mg/dl
8. Non stenotic carotid plaque
Moderate Risk 2 major ASCVD risk factors
Low Risk 0-1 major ASCVD risk factors
Major ASCVD (Atherosclerotic cardiovascular disease) Risk Factors
1. Age >/=45 years in Males &
3. Current Cigarette smoking or tobacco use
>/= 55 years in Females
2. Family history of premature
4. High blood pressure
ASCVD
5. Low HDL

Newer treatment goals and statin initiation thresholds based on the risk categories proposed by Lipid Association of India
in 2020.

Risk Group Treatment Goals Consider Drug Therapy

LDL-C (mg/dl) Non-HDL (mg/dl) LDL-C (mg/dl) Non-HDL (mg/dl)

Extreme Risk Group Category A <50 (Optional goal <OR = 30) <80 (Optional goal <OR = 60) >OR = 50 >OR = 80
Extreme Risk Group Category B >OR = 30 >OR = 60 > 30 > 60
Very High Risk <50 <80 >OR = 50 >OR = 80
High Risk <70 <100 >OR = 70 >OR = 100
Moderate Risk <100 <130 >OR = 100 >OR = 130
Low Risk <100 <130 >OR = 130* >OR = 160

* After an adequate non-pharmacological intervention for at least 3 months.

References : Management of Dyslipidaemia for the Prevention of Stroke : Clinical practice Recommendations from the Lipid Association of
India. Current Vascular Pharmacology,2022,20,134-155.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., H.No.31/82A-9-B Rashmi Nagar, Near BHU Hospital, Varanasi-221005

Page 10 of 12
 Patient NAME : Ms Reeta keshari
DOB/Age/Gender : 45 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11235979/RCL10417368 Barcode NO : YB709983
Referred BY : Self Sample Type : Spot Urine
....

Sample Collected : Jan 31, 2025, 10:13 AM Report Date : Jan 31, 2025, 12:15 PM.
Test Description Value(s) Unit(s) Reference Range

Urine Routine and Microscopic Examination

Physical Examination
Volume * 20 ml -
Colour * Pale yellow - Pale yellow
Transparency * Slightly Hazy - Clear
Deposit * Present - Absent
Chemical Examination
Reaction (pH) 6.5 - 4.5 - 8.0
Double Indicator
Specific Gravity 1.005 - 1.010 - 1.030
Ion Exchange
Urine Glucose (sugar) Negative - Negative
Oxidase / Peroxidase
Urine Protein (Albumin) Negative - Negative
Acid / Base Colour Excahnge
Urine Ketones (Acetone) Negative - Negative
Legals Test
Blood Negative - Negative
Peroxidase Hemoglobin
Leucocyte esterase Negative - Negative
Enzymatic Reaction
Bilirubin Urine Negative - Negative
Coupling Reaction
Nitrite Negative - Negative
Griless Test
Urobilinogen Normal - Normal
Ehrlichs Test
Microscopic Examination
Pus Cells (WBCs) * 1-2 /hpf 0-5
Epithelial Cells * 6-7 /hpf 0-4
Red blood Cells * Absent /hpf Absent
Crystals * Absent - Absent
Cast * Absent - Absent
Yeast Cells * Absent - Absent
Amorphous deposits * Absent - Absent
Bacteria * Absent - Absent
Protozoa * Absent - Absent
Interpretation:
URINALYSIS- Routine urine analysis assists in screening and diagnosis of various metabolic, urological, kidney and liver disorders.

Protein: Elevated proteins can be an early sign of kidney disease. Urinary protein excretion can also be temporarily elevated by strenuous
exercise, orthostatic proteinuria, dehydration, urinary tract infections and acute illness with fever

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., H.No.31/82A-9-B Rashmi Nagar, Near BHU Hospital, Varanasi-221005

Page 11 of 12
 Patient NAME : Ms Reeta keshari
DOB/Age/Gender : 45 Y/Female Report STATUS : Final Report
Patient ID / UHID : 11235979/RCL10417368 Barcode NO : YB709983
Referred BY : Self Sample Type : Spot Urine
Sample Collected : Jan 31, 2025, 10:13 AM Report Date : Jan 31, 2025, 12:15 PM.
Test Description Value(s) Unit(s) Reference Range

Glucose: Uncontrolled diabetes mellitus can lead to presence of glucose in urine. Other causes include pregnancy, hormonal disturbances,
liver disease and certain medications.

Ketones: Uncontrolled diabetes mellitus can lead to presence of ketones in urine. Ketones can also be seen in starvation, frequent vomiting,
pregnancy and strenuous exercise.

Blood: Occult blood can occur in urine as intact erythrocytes or haemoglobin, which can occur in various urological, nephrological and bleeding
disorders.

Leukocytes: An increase in leukocytes is an indication of inflammation in urinary tract or kidneys. Most common cause is bacterial urinary tract
infection.

Nitrite: Many bacteria give positive results when their number is high. Nitrite concentration during infection increases with length of time the
urine specimen is retained in bladder prior to collection.

pH: The kidneys play an important role in maintaining acid base balance of the body. Conditions of the body producing acidosis/ alkalosis or
ingestion of certain type of food can affect the pH of urine.

Specific gravity: Specific gravity gives an indication of how concentrated the urine is. Increased specific gravity is seen in conditions like
dehydration, glycosuria and proteinuria while decreased specific gravity is seen in excessive fluid intake, renal failure and diabetes insipidus.

Bilirubin: In certain liver diseases such as biliary obstruction or hepatitis, bilirubin gets excreted in urine.

Urobilinogen: Positive results are seen in liver diseases like hepatitis and cirrhosis and in cases of haemolytic anaemia.

*** End Of Report ***

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., H.No.31/82A-9-B Rashmi Nagar, Near BHU Hospital, Varanasi-221005

Page 12 of 12
 Terms and Conditions of Reporting

1. The presented findings in the Reports are intended solely for informational and interpretational purposes by the
referring physician or other qualified medical professionals possessing a comprehensive understanding of
reporting units, reference ranges, and technological limitations. The laboratory shall not be held liable for any
interpretation or misinterpretation of the results, nor for any consequential or incidental damages arising from
such interpretation.

2. It is to be presumed that the tests performed pertain to the specimen/sample attributed to the Customer's name
or identification. It is presumed that the verification particulars have been cleared out by the customer or his/her
representation at the point of generation of said specimen / sample. It is hereby clarified that the reports
furnished are restricted solely to the given specimen only.

3. It is to be noted that variations in results may occur between different laboratories and over time, even for the
same parameter for the same Customer. The assays are performed and conducted in accordance with standard
procedures, and the reported outcomes are contingent on the specific individual assay methods and equipment(s)
used, as well as the quality of the received specimen.

4. This report shall not be deemed valid or admissible for any medico-legal purposes.

5. The Customers assume full responsibility for apprising the Company of any factors that may impact the test
finding. These factors, among others, includes dietary intake, alcohol, or medication / drug(s) consumption, or
fasting. This list of factors is only representative and not exhaustive.